Now I have a thorough base from multiple authoritative sources. Here is the complete management guide:
Management of Acute Per Rectal (PR) Bleeding
Definition & Context
Hematochezia = passage of bright red blood, maroon-coloured blood, or blood clots per rectum. Usually indicates a lower GI source (distal to ligament of Treitz), but 15% of hematochezia cases arise from severe upper GI bleeding - most of these patients are haemodynamically unstable.
Approximately 95% of major lower GI bleeding (LGIB) arises from the colon; 5% from the small intestine.
Most common causes of LGIB by frequency:
| Cause | Frequency (%) |
|---|
| Diverticulosis | 26-31 |
| Internal haemorrhoids | 14-19 |
| Neoplasm | 6-20 |
| Colon ischaemia | 6-12 |
| Post-polypectomy bleeding | 3-8 |
| Inflammatory bowel disease | 2-9 |
| Angioectasias | 1-6 |
| Rectal ulcer | 0-6 |
| Infectious colitis | 0-5 |
Step 1 - Initial Assessment & Triage
A - Haemodynamic Evaluation
The first task is to determine severity and whether the patient is in hypovolaemic shock:
| Feature | Significance |
|---|
| HR >100 bpm | Active / significant bleeding |
| SBP <90 mmHg | Haemodynamic instability - requires urgent resuscitation |
| Postural hypotension (>20 mmHg drop) | Significant volume loss |
| Oliguria / reduced consciousness | Severe shock |
B - Risk Stratification
High-risk features warranting ICU-level care:
- Haemodynamic instability (shock)
- Active ongoing bright red bleeding or passage of clots
- Advanced age (median age of LGIB hospitalisation: 74 years)
- Comorbidities: renal failure, cirrhosis, cardiac disease, malignancy
- Coagulopathy or anticoagulant/antiplatelet use
- Secondary bleeding (onset after hospitalisation for another condition) - carries highest mortality
Step 2 - Immediate Resuscitation
Done simultaneously with assessment - do not delay.
IV Access & Fluids
- Insert two large-bore (14-16G) peripheral IV cannulae
- Commence crystalloid resuscitation (normal saline or Hartmann's solution) immediately
- Target: HR <100, SBP >90, urine output >0.5 mL/kg/hr
Blood Transfusion
- Cross-match 4-6 units packed red blood cells (PRBCs)
- Transfuse PRBCs to maintain Hb >70-80 g/L (or >90 in cardiac disease)
- Withhold/reverse anticoagulants (warfarin - give Vitamin K ± PCC; DOACs - specific reversal agents)
- Correct coagulopathy: Fresh Frozen Plasma if INR >1.5, Platelets if <50 x10⁹/L
- Withhold antiplatelet agents as appropriate
Monitoring
- Insert urinary catheter (monitor urine output)
- Continuous cardiac monitoring, pulse oximetry
- Central venous access if haemodynamically unstable or cardiac disease present
- Nasogastric tube insertion - if NGT lavage shows blood/coffee grounds, this identifies an upper GI source (stops further lower GI workup temporarily)
Investigations (Parallel with Resuscitation)
| Test | Purpose |
|---|
| FBC | Hb (degree of blood loss), WBC (infection/ischaemia) |
| Coagulation (PT/APTT/INR) | Coagulopathy, anticoagulant effect |
| U&E / Creatinine | Renal function, BUN:Cr ratio (upper vs lower source) |
| LFTs | Liver disease (varices risk) |
| ABG / Lactate | Severity, ischaemia |
| Group & cross-match | Prepare blood products |
| Serum glucose | Baseline |
BUN:Creatinine ratio >30 is most suggestive of an upper GI source of bleeding.
Passage of blood clots per rectum is the finding most predictive of a lower GI source.
Step 3 - Algorithm by Haemodynamic Status
PATHWAY A: Haemodynamic Instability (Shock)
Active bleeding + Hypovolaemic shock
↓
1. Aggressive resuscitation (IVF, blood, reverse coagulopathy)
↓
2. Exclude upper GI source (NGT lavage / urgent OGD)
↓
3. CT ANGIOGRAPHY (CTA) - FIRST LINE
• Detects bleeding ≥0.3-0.5 mL/min
• Sensitivity 85%, Specificity 92%, Accuracy ~100%
• Localises source before angiography
↓
CTA POSITIVE → Extravasation identified
↓
4. MESENTERIC ANGIOGRAPHY + EMBOLISATION
(within 90 minutes of positive CTA)
• Superselective embolisation - feasibility 98%
• Complication rate 4.6% (mainly bowel infarction)
• Superior mesenteric artery examined first (most common source)
↓
Bleeding controlled → Inpatient colonoscopy to identify/treat source
Bleeding continues → Consider surgery
PATHWAY B: Haemodynamically Stable (Significant Bleeding)
PR bleeding + Haemodynamically stable
↓
Resuscitation + Labs + Cross-match
↓
INPATIENT COLONOSCOPY (test of choice)
• After adequate bowel preparation
• Performed next-available basis (no proven benefit of <24h vs 24-96h
for stigmata identification, rebleeding, or transfusion requirements)
• Identifies source in 45-90% of cases
• Allows biopsy AND therapeutic intervention
↓
If normal:
Consider OGD (exclude upper GI source)
→ Capsule endoscopy (small bowel source)
→ CT angiography
→ Radionuclide (tagged RBC) scan
PATHWAY C: Minor Bleeding / Low Risk
- Arrange outpatient investigations (colonoscopy as outpatient)
- No urgent admission required if haemodynamically stable, self-limiting, low-risk features
Step 4 - Endoscopic Management
Colonoscopy is the diagnostic test of choice for haemodynamically stable LGIB:
- Precise localisation regardless of active bleeding or lesion type
- Allows biopsy
- Provides therapeutic intervention
Endoscopic Haemostasis Techniques (at Colonoscopy)
- Injection therapy - adrenaline (1:10,000) injection around bleeding point
- Mechanical clips (endoclips) - for diverticular bleeding, post-polypectomy
- Thermal coagulation - heater probe, APC (argon plasma coagulation)
- Band ligation - haemorrhoids
- After haemostasis of diverticular bleed: place submucosal tattoo at the site (for re-identification if re-bleeding occurs or surgery is needed)
Definitive or potential bleeding source identified in 45-90% of colonoscopies for LGIB. A non-bleeding potential source does not exclude a more proximal source.
Step 5 - Radiological Interventions
CT Angiography (CTA)
| Feature | Value |
|---|
| Bleeding rate needed for detection | ≥0.3-0.5 mL/min |
| Sensitivity | 85% |
| Specificity | 92% |
| Overall accuracy | ~100% |
| Key advantage | Fast, widely available, localises source, guides angiography |
| Limitation | Not therapeutic; requires active bleeding; radiation + IV contrast |
Mesenteric Angiography
- Requires bleeding ≥0.5-1.0 mL/min (optimal conditions)
- Reserved for: unstable patients unfit for colonoscopy, ongoing bleeding despite colonoscopy
- Must be performed within 90 minutes of a positive CTA (risk of bleeding stopping before procedure)
- Success rate: 25-70% (variable)
- Superselective transcatheter embolisation - has largely replaced vasopressin infusion
- If no prior localisation: examine superior mesenteric artery first (most common LGIB source)
Radionuclide (Tagged RBC) Scan
- Most sensitive for slow bleeding: detects rates of 0.1-0.5 mL/min
- Major disadvantage: only localises to a general abdominal area (poor precision, accuracy 24-91%)
- Used when CTA is negative or bleeding is intermittent/slow
- Requires active bleeding during the scan; follow promptly with angiography if positive
Step 6 - Surgical Management
Surgery is rarely required - most LGIB is self-limiting or controlled endoscopically/angiographically.
Indications for Surgery in LGIB
- Persistent haemodynamic instability despite active resuscitation
- Persistent or recurrent bleeding not controlled by endoscopy/angiography
- Transfusion >4 units PRBCs in 24 hours with active or recurrent bleeding
- Exsanguinating haemorrhage
Operative Approach
| Situation | Procedure |
|---|
| Bleeding source localised preoperatively | Segmental colectomy (preferred - lower morbidity) |
| Bleeding source NOT localised, active bleed | Subtotal colectomy (morbidity ~37%, mortality 11-33%) |
| Haemodynamically unstable, nonlocalised | Two-stage procedure: temporary end ileostomy + delayed ileoproctostomy |
| Stable, minimal comorbidities, nonlocalised | Single-stage ileoproctostomy |
The morbidity and mortality of surgery without preoperative localisation is significantly higher. All efforts to localise the source before the operating room are mandatory.
Step 7 - Source-Specific Management
| Source | Management |
|---|
| Diverticular bleed | Usually self-limiting (80%); colonoscopic haemostasis if active; embolisation; rarely surgery |
| Haemorrhoids | Rubber band ligation, sclerotherapy, haemorrhoidectomy for refractory cases |
| Colorectal cancer | Endoscopic palliation; surgical resection (elective or urgent) |
| Angiodysplasia | APC at colonoscopy; embolisation; rarely segmental resection |
| IBD (UC/Crohn's) | Medical therapy (steroids, biologics); surgery for refractory/fulminant cases |
| Colon ischaemia | Supportive care; surgery if perforation, gangrene, or clinical deterioration |
| Post-polypectomy bleed | Immediate endoscopic re-treatment (clips/injection); usually self-limiting |
| Anal fissure | Conservative (stool softeners, topical GTN/diltiazem); lateral internal sphincterotomy |
| Rectal varices | TIPS, banding, BRTO |
Management Algorithm Summary
ACUTE PR BLEEDING
↓
RESUSCITATION: 2x large-bore IV, crystalloids, cross-match
Withhold anticoagulants, correct coagulopathy
Insert urinary catheter, monitor vitals
↓
┌───────────────────────────────────┐
│ Haemodynamically UNSTABLE? │
└───────────────────────────────────┘
YES NO
↓ ↓
CTA first Bowel prep →
→ Angiography + Colonoscopy
Embolisation (next available)
↓ ↓
Controlled? Source found?
YES → Colonoscopy YES → Endoscopic Rx
NO → Surgery NO → OGD / Capsule /
CTA / RBC scan
↓
Still bleeding?
→ Surgery
Outcomes
- LGIB in-hospital mortality: <4% (most deaths from comorbid conditions, not bleeding itself)
- Worst prognosis: secondary bleed (onset during hospitalisation for another condition), malignancy, coagulopathy, haemodynamic instability, advanced age, male sex
- Best prognosis: haemorrhoids, anal fissures, polyps
Key References:
- Bailey & Love's Short Practice of Surgery, 28th Edition (p. 1405)
- Sabiston Textbook of Surgery (pp. 2189-2191)
- Mulholland & Greenfield's Surgery, 7th Edition (pp. 3197-3200)
- Harrison's Principles of Internal Medicine, 22nd Edition